UNSPSC 51332877: Thioridazine hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C21H26N2S2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4WCI67NK8M, chemically known as 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)- but more generally known as thioridazine hydrochloride, which bears US NIH Compound Identifier 5452. European Medicines Agency schedules Thioridazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04821MIG.

UNSPSC 51332877 Thioridazine hydrochloride, a Commodity code, nominally designates a specific antipsychotic pharmaceutical. However, the recent state and local procurement activity indexed under this code does not match its stated scope. Seminole County, Florida posted an IFB in June 2026 for naloxone and safe drug deactivation systems—opioid-overdose reversal medication and harm-reduction equipment wholly unrelated to thioridazine. The county's scope calls for annual delivery of 1,900 units of naloxone and 800 deactivation systems via quarterly shipments to the Seminole County Community Health Building in Sanford, with all shipping and delivery costs included in vendor proposals. This code shows little relevant recent activity aligned with thioridazine procurement itself; the tagged opportunity represents a classification mismatch rather than a signal of active demand for the pharmaceutical named in the code.

The single recent opportunity on record reflects Seminole County's community health initiative, with an IFB posted June 30, 2026 and a response deadline of July 26, 2023 (note the date inconsistency in the source record). Bidders must submit proposals electronically, comply with drug-free workplace and E-Verify requirements, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract term runs two years with a one-year renewal option and includes a three-month probationary termination clause. Vendors must be legally authorized to work in the United States. Procurement does not specify set-asides for disadvantaged enterprises, though FEMA funding may impose additional federal compliance obligations. No budget range is disclosed. This code does not represent a viable procurement category for pharmaceutical business development purposes; vendors targeting state and local health-related pharma procurement should monitor relevant therapeutic-class and drug-category UNSPSC codes rather than rely on this designation.